No Data
Genfleet Therapeutics (Shanghai), Inc. Class H (2595) Receives a Buy From Guotai Haitong
September 3 Share Buyback Roundup | Tencent and HSBC Holdings, among others, conducted share buybacks, with Tencent spending HK$100 million.
According to disclosure documents released by the Hong Kong Exchange on September 4, companies including $Tencent (00700.HK)$ and $HSBC Holdings (00005.HK)$ repurchased shares. ① $Tencent (00700.HK)$ repurchased 229,000 ordinary shares on September 3, involving an amount of HK$100 million, with a repurchase price per share ranging from HK$433 to HK$445.4. Since the resolution on the share repurchase mandate was passed, the cumulative number of securities repurchased stands at 43.6987 million shares, representing 0.47926% of the issued shares outstanding at the time the ordinary resolution was approved. ② $HSBC Holdings (00005.HK)$ on September
GenFang Medicine-B (02595) has a total deposited market capitalization of HK$1.955 billion, with shareholders depositing 43.7309 million shares into Standard Chartered Bank (Hong Kong).
On September 3, Jingfang Pharma-B (02595) saw a notable change in its stock holdings, with the total market value of these holdings reaching HK$1.955 billion, accounting for 19.65% of the company's
GenFang Medicine-B (02595.HK) repurchased 20,000 shares for HK$546,400 on September 3.
Gelonghui, September 3 — Jinfang Pharma-B (02595.HK) announced that on September 3, it repurchased 20,000 shares at a total cost of HK$546,400, at a repurchase price of HK$27.32 per share.
Share Buybacks on September 2 | Tencent, Li Auto-W, and others conduct buybacks, with Tencent spending HK$100 million
According to disclosures filed with the Hong Kong Exchange on September 3, companies including $Tencent (00700.HK)$ and $Li Auto-W (02015.HK)$ repurchased shares. ① $Tencent (00700.HK)$ repurchased 229,000 ordinary shares on September 2, involving an amount of HK$100 million, with repurchase prices ranging from HK$435.2 to HK$441 per share. Since the resolution authorizing the buyback was passed, the cumulative number of securities repurchased stands at 43.4697 million shares, representing 0.47675% of the issued shares outstanding at the time the ordinary resolution was approved. ② $Li Auto-W (02015.
GenFang Medicine-B (2595.HK): A Comprehensive Player in the RAS Therapeutic Landscape; PANRAS Molecular Glue Shows Best-in-Class Potential
Introduction to this report:We believe the company has built a broad portfolio